Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Cyclacel Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

31 Jul 2015 Reuters Investment Profile 12 $20.00

CYCC: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

04 Aug 2015 New Constructs, LLC 10 $25.00

CYCLACEL PHARMACEUTICALS INC PFD (CYCCP) 12-months forecast

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

01 Aug 2015 Pechala's Reports 1 $15.00

CYCLACEL PHARMACEUTICALS INC PFD (CYCCP) - REPORT FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

01 Aug 2015 Pechala's Reports 1 $25.00

ValuEngine Industry Report for Medical-Biomed/Genetics(CYCC)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

31 Jul 2015 ValuEngine, Inc. 10 $49.00

Value Graph: CYCLACEL PHARMAC -- CYCC

31 Jul 2015 Ford Investor Services, Inc. 1 $12.00

Wright Investors Service Comprehensive Report for Cyclacel Pharmaceuticals, Inc.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

27 Jul 2015 Wright Reports 56 $75.00

ValuEngine Industry Report for Medical-biomed/genetics(CYCC)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

24 Jul 2015 ValuEngine, Inc. 10 $49.00

TheStreet.com Ratings Stock Report For: CYCLACEL PHARMACEUTICALS (CYCC)

19 Jul 2015 TheStreet.com Ratings 5 $10.00

Cyclacel Pharmaceuticals

18 Jul 2015 S&P Capital IQ Quantitative Report 9 $104.00